期刊文献+

手性药物雷诺嗪的研究进展

下载PDF
导出
摘要 慢性心绞痛是缺血性心脏病的常见临床表现,严重影响人们的生活质量。随着人们生活水平的提高和生活方式的改变,以及人口趋于老龄化,心绞痛的发病率及死亡率呈逐年上升,心绞痛的治疗与新药的开发越来越受到关注。慢性稳定性心绞痛的重要病理生理机制是暂时性缺血、缺氧,是由血和氧的供需间平衡失调所致,
作者 廖明琪 王婷
出处 《中国药师》 CAS 2013年第2期203-206,共4页 China Pharmacist
  • 相关文献

参考文献26

  • 1Frye RL, August P, Brooks MM, et al. A randonfized trial of thera- pies for Type 2 diabetes and coronary artery disease [ J l.. N Engl J Med, 2009,360:2503 -2515.
  • 2Stone P. Ranolazine : new paradigm for management of myocardial is- chemia, myocardial dysfunction, and arrhythmias[ J]. Cardiol Clin, 2008,26:603-614.
  • 3Fraker TD, Fihn SD. Chronic angina focused update of the ACC/ AHA 2002 guidelines for the management of patients with chronic sta- ble angina [ J]. Coll Cardiol,2007,50:2264-2274.
  • 4Stanley WC. Ranolazine : new approach for the treatment of stable an- gina pectoris [ J]. Expert Rev Cardiovasc Ther ,2005 ,3 :821-829.
  • 5Chaitman BR, Skettino SL, Parker JO, et al. MARISA Investigators. Anti-ischemic effects and long-term survival during ranolazine mono- therapy in patients with chronic severe angina [ J ]. Coll Cardiol, 2004,43 : 1375-1382.
  • 6Hale SL, Shryock JC, Belardinelli L, et al. Late sodium current in- hibition as a new cardioprotective approach [ J ]. Mol Cell Cardiol, 2008,44:954-967.
  • 7Chairman BR. Ranolazine for the treatment of chronic angina and po- tential use in other cardiovascular conditions [J]. Circulation,2006, 113:2462-2472.
  • 8Adakkak M, Camara AK, Heisffer JS, et al. Ranolazine reduces Ca2 + overload and oxidative stress and improves mitochondrial integri- ty to protect against ischemia reperfusion injury in isolated hearts [J]. Pharmacol Res ,2011,64(4) :381-392.
  • 9Antzelevitch C,Belardinelli L, Zygmunt AC, et al. Electrophysiologi- cal effects of ranolazine, a novel antianginal agent with antiarrhythmic properties [ J]. Circulation,2004,110:904-910.
  • 10Sicouri S, Glass A, Belardinelli L, et al. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations [ J]. Heart Rhythm ,2008,5 : 1019-1026.

二级参考文献16

  • 1Francotte E.J Chromatogr,1994,666:565
  • 2Wang Jin-xia et al.Arzneim-Forsch,1999,49(3):193
  • 3Jain P Dasgupta et al.J Clin Pharmacol,1990,38:111
  • 4Wyatt Katrina M et al.Biochem Pharmacol,1995,50(10):1599
  • 5G Wcco et al.J Cardiovasc Pharmacol,1992,20:131
  • 6Pepine Carl J et al.Am J Cardiol,1999,84(1):46
  • 7W J Herron,J Eadie,A D Penman.J Chromatogr,A 1995,712(1):55
  • 8Delee E,Le Garrec L,Jullien I et al.Chromtographia,1987,24:357
  • 9Y Okamoto,M Kawashima,K Hatada.J Chromatogr,1986,363:173
  • 10I W Wainer,M C Alembik,J Chromatogr,1986,358:5

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部